Abstracts

89 Avert: Global Information and Education on HIV and AIDS. (2019). Funding for HIV and AIDS . Bekker, L. G., Rebe, K., Venter, F., Maartens, G., Moorhouse, M., Conradie, F., Wallis, C., Black, V., Harley, B., & Eakles, R. (2016). Southern African guidelines on the safe use of pre-exposure prophylaxis in persons at risk of acquiring HIV-1 infection. Southern African Journal of HIV Medicine, 17 (1), 1–11. Breslow, J. M. (2013, December 6). Nelson Mandela’s mixed legacy on HIV/AIDS. PBS. Central Intelligence Agency. (2016). Country comparison: HIV/AIDS - adult prevalence rate. Chigwedere, P., Seage III, G. R., Gruskin, S., Lee, T. H., & Essex, M. (2008). Estimating the lost benefits of antiretroviral drug use in South Africa. JAIDS Journal of Acquired Immune Deficiency Syndromes, 49 (4), 410–415. Coetzee, D. (2001). South African education and the ideology of patriarchy. African Journal of Education, 21(4), 300–304. Cohen, M. (2019). Quick take: South Africa’s hopes. Bloomberg. Division of HIV/AIDS Prevention; National Center for HIV/ AIDS, Viral Hepatitis, STD, and TB Prevention; Centers for Disease Control and Prevention. (2019). About HIV/AIDS. Factors that contribute to the hidden epidemic. (1997). In T. R. Eng &W. T. Butler (Eds.), The hidden epidemic: Confronting sexually transmitted diseases (pp. 69– 117). National Academies Press. Getahun, H., Gunneberg, C., Granich, R., & Nunn, P. (2010). HIV infection—associated tuberculosis: The epidemiology and the response. Clinical Infectious Diseases, 50 (Supplement 3), S201–S207. Henry J. Kaiser Family Foundation. (2019). The U.S. President’s emergency plan for AIDS relief (PEPFAR). International Partnership for Microbicides. (2010). Pathway to microbicide access . Jewkes, R. K., Levin, J. B., & Penn-Kekana, L. A. (2003). Gender inequalities, intimate partner violence and HIV preventive practices: Findings of a South African cross-sectional study. Social Science & Medicine, 56 (1), 125–134. Joseph Davey, D.L., Bekker, L.-G., Gomba, Y., Coates, T., Myer, L., & Johnson, L. F. (2019). Modelling the potential impact of providing preexposure prophylaxis in pregnant and breastfeeding women in South Africa. Aids, 33 (8), 1391–1395. PrEP Watch. (2020). AIDS Vaccine Advocacy Coalition . Simbayi, L. C., Zuma, K., Zungu, N., Moyo, S., Marinda, E., Jooste, S., Mabaso, M., Ramlagan, S., North, A., Van Zyl, J., Mohlabane, N., Dietrich, C., Naidoo, I., & SABSSM V Team. (2019). South African National HIV Prevalence, Incidence, Behavior, and Communication Survey, 2017: Towards achieving the UNAIDS 90-90-90 targets . HSRC Press. South African History Online. (2011). HIV/AIDS in South Africa timeline, 1940s-2009 . South African History Online. (2017). History of slavery and early colonisation in South Africa. Trinitapoli, J., & Weinreb, A. (2012). Religion and AIDS in Africa . Oxford University Press. UNAIDS (2019). South Africa. Venter, W. D. F., Cowan, F., Black, V., Rebe, K., & Bekker, L. (2015). Pre-exposure prophylaxis in Southern Africa: Feasible or not? Journal of the International AIDS Society, 18 (4, Suppl 3), 35–41. Walensky, R. P., Park, J. E., Wood, R., Freedberg, K. A., Scott, C. A., Bekker, L., Losina, E., Mayer, K. H., Seage, G. R., & Paltiel, A. D. (2012). The cost-effectiveness of pre-exposure prophylaxis for HIV infection in South African women. Clinical Infectious Diseases, 54 (10), 1504–1513. Warnke, D., Barreto, J., &Temesgen, Z. (2007). Antiretroviral drugs. Journal of Clinical Pharmacology, 47 (12), 1570–1579. World Health Organization. (2017). HIV/AIDS. References